Tech Company Financing Transactions
Pretzel Therapeutics Funding Round
Pretzel Therapeutics, operating out of Waltham, received investment from The Mito Fund.
Transaction Overview
Company Name
Announced On
7/14/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1601 Trapelo Rd
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Undisclosed
Website
Email Address
Overview
Pretzel was founded by some of the world's foremost researchers in mitochondrial biology and is led by accomplished experts in drug discovery, drug development, and company foundation. Our deep expertise in mitochondrial biology enables us to potentially address a wider range of diseases driven by mitochondrial dysfunction than ever before.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Parrish
Chief Operating Officer
Baruch Harris
Chief Scientific Officer
Gabriel Martinez
Co-Founder
Claes Gustafsson
Co-Founder
Michal Minczuk
Vice President
Andrew Griffin
Browse more venture capital transactions:
Prev: 7/14/2025: TitanFile venture capital transaction
Next: 7/14/2025: Opper AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs